Protara Therapeutics to Present at the Jefferies Virtual London Healthcare Conference
November 11 2020 - 7:00AM
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage
company developing transformative therapies for the treatment of
cancer and rare diseases with significant unmet needs, today
announced that its Chief Executive Officer, Jesse Shefferman, will
present at the Jefferies Virtual London Healthcare Conference on
Wednesday, November 18, 2020 at 1:45pm ET.
A webcast of the presentation can be accessed by
visiting the Events and Presentations section of the Company’s
website: https://ir.protaratx.com. The webcast will be archived on
the Company’s website for 90 days following the presentation.
About Protara Therapeutics,
Inc.
Protara is committed to identifying and
advancing transformative therapies for people with cancer and rare
diseases with limited treatment options. Protara’s portfolio
includes its lead program, TARA-002, an investigational cell-based
therapy being developed for the treatment of non-muscle invasive
bladder cancer and lymphatic malformations, and IV Choline
Chloride, an investigational phospholipid substrate replacement
therapy for the treatment of intestinal failure-associated liver
disease. For more information, visit www.protaratx.com.
Company Contact:
Blaine DavisProtara
TherapeuticsBlaine.Davis@protaratx.com646-844-0337
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Jul 2023 to Jul 2024